Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
ProShares Ultra Bloomberg Crude Oil ETF
UCO
5
United States Gasoline Fund Lp
UGA
US Stock MarketDetailed Quotes
Vertex Pharmaceuticals (VRTX)
- 444.280
- +4.230+0.96%
Close Apr 14 16:00 ET
- 444.280
- 0.0000.00%
Post 20:01 ET
113.01BMarket Cap29.00P/E (TTM)
444.790High435.280Low1.45MVolume435.280Open440.050Prev Close640.41MTurnover0.57%Turnover Ratio29.00P/E (Static)254.36MShares510.77052wk High6.05P/B112.66BFloat Cap362.50052wk Low--Dividend TTM253.57MShs Float519.880Historical High--Div Yield TTM2.16%Range %7.250Historical Low443.036Avg Price1Lot Size
Vertex Pharmaceuticals (VRTX) Key Financial Indicators
VRTX Earnings per Share (EPS)
According to the latest financial report of Vertex Pharmaceuticals, the latest earnings per share (TTM) for the company is 4.65. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
VRTX Free Cash Flow (FCF)
Interested in knowing about Vertex Pharmaceuticals's free cash flow? The latest report shows it as 348.60M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
VRTX Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Vertex Pharmaceuticals shows that the company's current ratio is 2.90, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
VRTX Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Vertex Pharmaceuticals, the quick ratio is 2.24, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
VRTX Return on Equity (ROE)
Want to learn more about the financial health of Vertex Pharmaceuticals? The latest ROE figure is 6.62%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
VRTX Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Vertex Pharmaceuticals, the total asset return on investment (ROA) is 4.72%.
Currency: USD
Quarterly
Loading...
VRTX Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Vertex Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at 85.39%.
Currency: USD
Quarterly
Loading...
VRTX Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Vertex Pharmaceuticals, the net profit margin is 37.34%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
US President Trump stated in a recent interview that the US war with Iran has 'ended.' According to Axios, Pakistan, Egypt, and Turkey have
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm